NRx is seeking to have the FDA grant its coronavirus treatment breakthrough designation, based on new, favorable data on the drug. NRXP stock is climbing on the news. More
Articles
CANF Stock: The Cancer-Fighting News Sending Can-Fite Higher Today
Can-Fite BioPharma is rising on Wednesday following positive Phase 2 data on its liver cancer treatment. Can it help turn CANF stock around? More
Polygon Looks Like Good Value Here As Its Popularity Grows
Polygon looks like good value here given its prospects next year. MATIC crypto will likely keep rising over the next year just like it did during Q3 as Polygon Defi apps become more popular. More
Who Is Nick Szabo? 8 Things to Know About the Man Elon Musk Thinks Created Bitcoin.
Linguistic studies have suggested that Nick Szabo authored the famous Bitcoin white paper. Now, Elon Musk says he agrees. More
Alphabet Stock Is Set to Soar to Over $4,000 Next Year
GOOG stock is worth over $4,000 per share, or 37% above today's price based on the company's expected strong FCF performance next year. More
American Airlines Stock Is Diving Into Long-Term Support Levels
AAL stock should find support above the pandemic lows. The conditions now, although not perfect, are far better than the 2020 crisis. More
Look for SoFi Stock to Rebound Back to $19
Look for SOFI stock to rebound quite significantly. SOFI stock seems at least 31% undervalued on forecast revenue growth of 44% next year. More
